Ongoing clinical trials in molecular imaging and radiotheranostics. Sorted by date of last update.
Dosimetry of Tc-99m-Tilmanocept
Phase 1
Last update: May 5
Different Doses of Olaparib Given with Radium-223 in Men with Advanced Prostate Cancer with Bone Metastasis
Phase 1b/2 Study of Combination Lu-177 Girentuximab Plus Cabozantinib and Nivolumab in Treatment naïve Patients with Advanced Clear Cell RCC
Evaluation of SIRT Followed by Immunotherapy for Treatment of Hepatocellular Carcinoma with Portal Vein Thrombosis (IOSPHERE)
Phase 2
Lu-177-DOTA-EB-TATE in Adult Patients with Metastatic, Radioactive Iodine Non-Responsive Oncocytic (Hurthle-Cell) Thyroid Cancer
The Study of Lu-177-TLX591 Plus SOC versus SOC Alone in Patients with mCRPC (ProstACT Global)
Phase 3
Comparing Retreatment of Lu-177-DOTATATE PRRT versus the Usual Treatment in Patients with Metastatic Unresectable Gastroenteropancreatic Neuroendocrine Tumors, NET RETREAT Trial
Last update: May 4
Italian Prospective Observational Study Assessing the Effectiveness and Outcomes Associated with Lutathera Treatment in GEP-NETs (REAL-LU)
N/A
Testing Lutetium Lu-177 Dotatate in Patients with Somatostatin Receptor Positive Advanced Bronchial Neuroendocrine Tumors
Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu-177 Edotreotide Therapy in Pediatric Participants with SSTR-positive Tumors (KinLET)
Last update: May 1